
Full Catalog pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26
| Full Catalog (page 1) | |||||||
|---|---|---|---|---|---|---|---|
| Product Number | Product Name | Molecular Formula | Cas. No. | Description | Notes | Alt. Name | Alt. Name 2 |
| BA 0001 | 7-Deaza-dA CEP | C48H53N6O7P | 107134-59-8 | The N7 imidazole nitrogen of purine nucleosides is known to take part in non-Watson-Crick hydrogen bonding and in metal chelation. "Deleting" the N7 nitrogen by replacing it with a CH group is a useful modification that has been accomplished in DNA oligonucleotides using the phosphoramidite of 2'-deoxytubercidin, namely 7-Deaza-dA CEP.1, which was useful in showing that N7 of dA is an important hydrogen bond acceptor site for the endodeoxyribonuclease EcoRI. 1. (a) Seela, F.; Kehne, A. Biochemistry 1987, 26, 2232-2238. (b) Seela, F.; Berg, H.; Rosemeyer, H. Biochemistry 1989, 28, 6193-6198. | Useful for modification of base pairing and metal chelating characterisitcs of purine nucleosides through elimination of the N7nitrogen. | N6-Benzoyl-7-deaza-3'-O-[(diisopropylamino)(2-cyanoethoxy)phosphino]-5'-O-(4,4'-dimethoxytrityl)-2'-deoxyadenosine | |
| BA 0002 | N6-Methyl-dA CEP |
C41H50N7O6P | 105931-58-6 | 3'-O-[(Diisopropylamino)(2-cyanoethoxy)phosphino]-5'-O-(4,4'-dimethoxytrityl)-N6-methyl-2'-deoxyadenosine | |||
| BA 0003 | 3'-dA CEP | C47H52N7O7P | 207347-42-0 | N6-Benzoyl-2'-O-[(diisopropylamino)(2-cyanoethoxy)phosphino]-5'-O-(4,4'-dimethoxytrityl)-3'-deoxyadenosine | |||
| BA 0004 | 8-Bromo-dA CEP | C43H52BrN8O6P | 207906-54-5 | 8-Bromo-3'-O-[(diisopropylamino)(2-cyanoethoxy)phosphino]-5'-O-(4,4'-dimethoxytrityl)-N6-(dimethylaminomethylidene)-2'-deoxyadenosine | |||
| BA 0005 | 8-Oxo-dA CEP | C47H52N7O8P | 142979-42-8 | N6-Benzoyl-3'-O-[(diisopropylamino)(2-cyanoethoxy)phosphino]-5'-O-(4,4'-dimethoxytrityl)-8-oxo-2'-deoxyadenosine | |||
| BA 0007 | 5-Fluoro-O4-TMP-dU CEP |
C48H56FN4O8P | 198080-36-3 | The convertible nucleoside 5-Fluoro-O4-TMP-dU CEP allows the formation of N4-alkyl-5-fluoro-dC residues by reaction with an alkyl amine. | 3'-O-[(Diisopropylamino)(2-cyanoethoxy)phosphino]-5'-O-(4,4'-dimethoxytrityl)-5-fluoro-O4-(2,4,6-trimethylphenyl)-2'-deoxyuridine | ||
| BA 0008 | 7-Deaza-dG CEP | C44H54N7O7P | 121767-97-3 | G-Rich regions in nucleic acids often display disrupted Watson-Crick base-pairing due to the ability of dG and G residues to enter into non-Watson-Crick inter- and intramolecular hydrogen bonding. A solution to this problem is to replace the N7 nitrogen atom on the guanine nucleobase with a CH group, obviating the possibility of hydrogen bonding at that position. For studies on alternating d(G-C)3 and d(C-G)3 hexanucleotides containing 7-deaza-2'-deoxyguanosine or 8-aza-7-deaza-2'-deoxyguanosine (BA 0242) in place of dG, see: Seela, F.; Driller, H. Nucleic Acids Res. 1989, 17(3), 901-910. We also now offer 7-Deaza-G CEP (BA 0323) for RNA synthesis. |
Installation of 7-Deaza-dG residues in G-rich regions can disrupt unwanted hydrogen bonding. | 7-Deaza-3'-O-[(diisopropylamino)(2-cyanoethoxy)phosphino]-5'-O-(4,4'-dimethoxytrityl)-N2-(dimethylaminomethylidene)-2'-deoxyguanosine | |
| BA 0009 | 8-Bromo-dG CEP | C43H52BrN8O7P | 198080-37-4 | 8-Bromo-3'-O-[(diisopropylamino)(2-cyanoethoxy)phosphino]-5'-O-(4,4'-dimethoxytrityl)-N2-(dimethylaminomethylidene)-2'-deoxyguanosine | |||
| BA 0010 | 8-Oxo-dG CEP | C44H54N7O9P | 143060-53-1 | 3'-O-[(Diisopropylamino)(2-cyanoethoxy)phosphino]-5'-O-(4,4'-dimethoxytrityl)-N2-isobutyryl-8-oxo-2'-deoxyguanosine | |||
| BA 0011 | 4-Thio-dT CEP | C43H52N5O7PS | None found | 4-Thio-T CEP | S-(2-Cyanoethyl)-3'-O-[(diisopropylamino)(2-cyanoethoxy)phosphino]-5'-O-(4,4'-dimethoxytrityl)-4-thiothymidine | ||
| BA 0012 | Carboxy-dT CEP | C43H51N4O10P | 198080-38-5 | 5-(E-2-Carbomethoxyvinyl)-3'-O-[(diisopropylamino)(2-cyanoethoxy)phosphino]-5'-O-(4,4'-dimethoxytrityl)-2'-deoxyuridine | |||
| BA 0013 | 2-Thio-dT CEP | C48H55N4O8PS | 156783-23-2 and 156783-15-2 | 2-Thio-T CEP | 3'-O-[(Diisopropylamino)(2-cyanoethoxy)phosphino]-5'-O-(4,4'-dimethoxytrityl)-N3/O4-toluyl-2-thiothymidine | ||
| BA 0014 | Biotin-dT CEP | C69H89N8O12PS | 198080-40-9 | 5-[E-2-[N-[N-[N1-(4-t-Butylbenzoyl)-D-(+)-biotinyl]-6-aminohexyl]carboxamido]vinyl]-3'-O-[(diisopropylamino)(2-cyanoethoxy)phosphino]-5'-O-(4,4'-dimethoxytrityl)-2'-deoxyuridine | |||
| BA 0015 | Amino-modifier-C6-dT CEP | C50H62F3N6O10P | 210534-16-0 | 3'-O-[(Diisopropylamino)(2-cyanoethoxy)phosphino]-5-[E-2-[N-[6-(trifluoroacetamido)hexyl]carboxamido]vinyl]-5'-O-(4,4'-dimethoxytrityl)-2'-deoxyuridine | |||
| BA 0016 | 2'-Deoxynebularine CEP | C40H47N6O6P | 178925-28-5 | 3'-O-[(Diisopropylamino)(2-cyanoethoxy)phosphino]-5'-O-(4,4'-dimethoxytrityl)-2'-deoxynebularine | |||
| BA 0017 | O6-Phenyl-dI CEP |
C46H51N6O7P | 133471-07-5 | The convertible nucleoside O6-Phenyl-dI CEP allows the formation of N6-alkyl-dA residues through reaction with alkyl amines. | 3'-O-[(Diisopropylamino)(2-cyanoethoxy)phosphino]-5'-O-(4,4'-dimethoxytrityl)-O6-phenyl-2'-deoxyinosine | ||
| BA 0021 | 2-Aminopurine CEP | C43H53N8O6P | 178925-41-2 | ||||
| BA 0030 | 5’-Amino-modifier-5 CEP | C33H44N3O4P | 612548-86-4 | ||||
| BA 0031 | Spacer-9 CEP | C36H49N2O7P | 146668-73-7 | ||||
| BA 0032 | Spacer-C3 CEP | C33H43N2O5P | 110894-23-0 | ||||
| BA 0033 | dSpacer CEP | C35H45N2O6P | 129821-76-7 | ||||
| BA 0034 | 5’-Amino-modifier-C6-TFA CEP |
C17H31F3N3O3P | 133975-85-6 | ||||
| BA 0036 | 5’-Amino-modifier-C3-TFA CEP |
C14H25F3N3O3P | 853955-89-2 | ||||
| BA 0037 | Thiol-modifier-C6-S-S CEP |
C42H61N2O5PS2 | 148254-21-1 | ||||
| BA 0038 | Biotin-TEG CEP | C52H76N5O11PS | 198080-44-3 | ||||
| BA 0039 | Cholesteryl-TEG CEP | C70H106N3O11P | 873435-29-1 | ||||